Skip to main content
Clinical Trials/JPRN-UMIN000022440
JPRN-UMIN000022440
Recruiting
未知

Clinical trials for the safety and efficacy of the combination of XELOX,the colorectal cancer radical resection adjuvant chemotherapy and of chronic hepatitis therapeutic agent 3 oxygelmillpropionic acid polymer.(Phase 1 test) - Seroshion test (adjuvant chemotherapy)

Osaka University Hospital0 sites5 target enrollmentJune 1, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Colorectal cancer
Sponsor
Osaka University Hospital
Enrollment
5
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients who could not resect curatively. 2\) Patients with active double cancer. 3\) Patients with severe drug hypersensitivity, or with a history of drug allergy. 4\) Patients with serious complications (heart failure, renal failure, liver failure, bleeding ulcer, watery diarrhea, intestinal paralysis, intestinal obstruction, severe diabetes). 5\)Patients of cirrhosis with jaundice or of suspected cirrhosis of the liver. 6\)Patients with the history of chronic hepatitis B and with the experience of Seroshion. 7\)Patients with active infection. 8\)Women with the possibility of pregnancy,during pregnancy,with the hope of pregnancy,or with breast\-feeding. 9\)Patients with mental severe disorder. 10\)Other cases who doctor determines that patients are unsuitable for safely carrying out the present study.

Outcomes

Primary Outcomes

Not specified

Similar Trials